Journal of Cellular and Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
29(1)
Published: Jan. 1, 2025
ABSTRACT
Renal
fibrosis
(RF)
is
a
crucial
pathological
factor
in
the
progression
of
chronic
kidney
disease
(CKD)
to
end‐stage
renal
failure,
and
accurate
noninvasive
assays
monitor
are
needed.
Circular
RNAs
(circRNAs)
noncoding
that
can
be
used
as
diagnostic
biomarkers
therapeutic
targets
for
human
diseases.
In
this
study,
we
analysed
expression
hsa_circ_0008925
urinary
tubular
cells
investigated
its
role
fibrosis.
Urinary
samples
were
collected
from
CKD
patients
with
varying
degrees
fibrosis;
epithelial
isolated
using
magnetic
bead
sorting.
moderate–severe
fibrosis,
was
elevated
compared
no
mild
Spearman
correlation
analysis
indicated
positively
correlated
serum
creatinine
(Scr,
rs
=
0.424,
p
0.031).
The
TGF‐β1‐treated
HK‐2
vitro.
Silencing
siRNA
inhibited
TGF‐β1‐induced
HK2
cells.
RNA
pull‐down
mass
spectrometric
analyses
serine/arginine‐rich
splicing
6
(SRSF6)
downstream
hsa_circ_0008925.
mmu_circ_0002215
inhibiting
SRSF6
alleviated
UUO
model
vivo.
Inhibiting
hsa_circ_0008925/SRSF6
vitro
These
findings
suggest
targeting
pathway
could
hold
promise
potential
strategy
treating
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 17, 2023
Abstract
Chronic
kidney
disease
(CKD)
is
estimated
to
affect
10–14%
of
global
population.
Kidney
fibrosis,
characterized
by
excessive
extracellular
matrix
deposition
leading
scarring,
a
hallmark
manifestation
in
different
progressive
CKD;
However,
at
present
no
antifibrotic
therapies
against
CKD
exist.
fibrosis
identified
tubule
atrophy,
interstitial
chronic
inflammation
and
fibrogenesis,
glomerulosclerosis,
vascular
rarefaction.
Fibrotic
niche,
where
organ
initiates,
complex
interplay
between
injured
parenchyma
(like
tubular
cells)
multiple
non-parenchymal
cell
lineages
(immune
mesenchymal
located
spatially
within
scarring
areas.
Although
the
mechanisms
are
complicated
due
kinds
cells
involved,
with
help
single-cell
technology,
many
key
questions
have
been
explored,
such
as
what
kind
renal
tubules
profibrotic,
myofibroblasts
originate,
which
immune
how
communicate
each
other.
In
addition,
genetics
epigenetics
deeper
that
regulate
fibrosis.
And
reversible
nature
epigenetic
changes
including
DNA
methylation,
RNA
interference,
chromatin
remodeling,
gives
an
opportunity
stop
or
reverse
therapeutic
strategies.
More
marketed
(e.g.,
RAS
blockage,
SGLT2
inhibitors)
developed
delay
progression
recent
years.
Furthermore,
better
understanding
also
favored
discover
biomarkers
fibrotic
injury.
review,
we
update
advances
mechanism
summarize
novel
treatment
for
CKD.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: March 25, 2023
Abstract
Kidney,
bladder,
and
prostate
cancer
are
the
three
major
tumor
types
of
urologic
system
that
seriously
threaten
human
health.
Circular
RNAs
(CircRNAs),
special
non-coding
with
a
stabile
structure
unique
back-splicing
loop-forming
ability,
have
received
recent
scientific
attention.
CircRNAs
widely
distributed
within
body,
important
biologic
functions
such
as
sponges
for
microRNAs,
RNA
binding
proteins,
templates
regulation
transcription
protein
translation.
The
abnormal
expression
circRNAs
in
vivo
is
significantly
associated
development
tumors.
now
emerged
potential
biomarkers
diagnosis
prognosis
tumors,
well
targets
new
therapies.
Although
we
gained
better
understanding
circRNA,
there
still
many
questions
to
be
answered.
In
this
review,
summarize
properties
detail
their
function,
focusing
on
effects
circRNA
proliferation,
metastasis,
apoptosis,
metabolism,
drug
resistance
kidney,
cancers.
Nucleic Acids Research,
Journal Year:
2023,
Volume and Issue:
52(D1), P. D1365 - D1369
Published: Oct. 11, 2023
Abstract
Systematic
integration
of
lncRNA-disease
associations
is
great
importance
for
further
understanding
their
underlying
molecular
mechanisms
and
exploring
lncRNA-based
biomarkers
therapeutics.
The
database
long
non-coding
RNA-associated
diseases
(LncRNADisease)
designed
the
above
purpose.
Here,
an
updated
version
(LncRNADisease
v3.0)
has
curated
comprehensive
lncRNA
(including
circRNA)
disease
from
burgeoning
literatures.
LncRNADisease
v3.0
exhibits
over
2-fold
increase
in
experimentally
supported
associations,
with
a
total
25440
entries,
compared
to
last
version.
Besides,
each
pair
assigned
confidence
score
based
on
experimental
evidence.
Moreover,
all
between
lncRNAs/circRNAs
are
classified
into
general
causal
representing
whether
lncRNAs
or
circRNAs
can
directly
lead
development
progression
corresponding
diseases,
15721
9719
respectively.
In
case
study,
we
used
data
calculate
phenotypic
similarity
human
mouse
lncRNAs.
This
will
continue
serve
as
valuable
resource
potential
clinical
applications
related
circRNAs.
freely
available
at
http://www.rnanut.net/lncrnadisease.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2024,
Volume and Issue:
43(1)
Published: Jan. 2, 2024
Abstract
Background
Cisplatin
(CDDP)-based
chemotherapy
is
a
standard
first-line
treatment
for
metastatic
bladder
cancer
(BCa)
patients,
and
chemoresistance
remains
major
challenge
in
clinical
practice.
Circular
RNAs
(circRNAs)
have
emerged
as
essential
regulators
carcinogenesis
progression.
However,
the
role
of
circRNAs
mediating
CDDP
chemosensitivity
has
yet
to
be
well
elucidated
BCa.
Methods
CircSTX6
(
hsa_circ_0007905
)
was
identified
by
mining
public
circRNA
datasets
verified
Sanger
sequencing,
agarose
gel
electrophoresis,
RNase
R
qRT-PCR
assays.
Then,
function
experiments
were
performed
evaluate
effects
circSTX6
on
BCa
metastasis.
Luciferase
reporter
assay,
RNA
pull-down,
immunoprecipitation
(RIP),
stability
Fluorescence
situ
hybridization
(FISH)
Immunofluorescence
(IF)
conducted
interaction
among
,
miR-515-3p
PABPC1
SUZ12
.
Animal
explore
tumor
metastasis
sensitivity.
Results
We
that
significantly
upregulated
samples
cells
Functionally,
promoted
cell
migration
invasion
both
vitro
vivo
Mechanistically,
could
act
sponge
abolish
its
effect
Moreover,
confirmed
increase
mRNA
interacting
with
stabilizer
subsequently
promote
expression
SUZ12.
Importantly,
silencing
improved
CDDP-resistant
CDDP.
Furthermore,
analysis
supported
knockdown
attenuated
resistance
tumors.
Conclusion
These
studies
demonstrate
plays
pivotal
chemoresistance,
potential
serve
therapeutic
target
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 2, 2025
Clear
cell
renal
carcinoma
(ccRCC)
represents
the
most
prevalent
subtype,
accounting
for
nearly
80%
of
all
RCC
cases.
Recent
research
has
shown
that
high
expression
circular
non-coding
RNA
(circRNA)
is
associated
with
poor
prognosis
in
patients
clear
(ccRCC),
however,
underlying
mechanism
remains
unclear.
After
analysing
self-sequenced
cancer
and
paracancer
circRNA
sequencing
data
comparing
it
GEO
public
database,
we
discovered
circASAP1
was
significantly
up-regulated
cancers.
We
also
tested
levels
102
found
metastasis.
The
interaction
between
circASAP1,
HNRNPC
their
downstream
target
genes
confirmed
through
experiments
such
as
pull-down,
RIP
fluorescence
situ
hybridisation.
A
series
vitro
vivo
functional
were
performed
to
verify
effects
on
proliferation
Circular
analysis
revealed
markedly
elevated
ccRCC,
a
significant
association
observed
Actinomycin
D,
RNase
R,
well
hybridization
(FISH)
analyses
ring
structure
cytoplasmic
localization
circASAP1.
High
ccRCC
proliferative
viability,
invasion,
metastasis
CCK-8,
transwell,
plate
cloning,
EdU
experiments.
Interaction
by
immunoprecipitation,
FISH,
silver
staining,
mass
spectrometry.
Experiments
using
truncated
isoforms
demonstrated
amino
acids
16–87
bound
Proteins
altered
enriched
ferroptosis
pathway
Kyoto
Encyclopedia
Genes
Genomes
enrichment
analysis.
relationship
ASAP1/HNRNPC/GPX4
axis
experimental
data,
which
further
rescue
influenced
tumor
growth
animal
predicted
ccRCC.
circASAP1/HNRNPC/GPX4
provides
novel
directions
potential
targets
treatment.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(19)
Published: April 21, 2023
MicroRNAs
(miRNAs)
can
act
as
oncogenes
or
tumor
suppressors,
capable
of
up
down-regulating
gene
expression
during
tumorigenesis;
they
are
diagnostic
biomarkers
therapeutic
targets
for
tumors.
To
detect
low
abundance
intracellular
oncogenic
miRNAs
(onco-miRNAs)
and
realize
synergistic
therapy
onco-miRNAs
a
smart
nano-theranostic
platform
based
on
dual-miRNAs
guided
self-feedback
tetrahedral
entropy-driven
DNA
circuit
is
created.
The
delivery
vehicle
framework,
in
which
the
achieves
self-feedback,
between
an
situ
amplification
activation
suppressor
release.
test
this
platform,
selected,
miRNA-155,
up-regulated
miRNA,
cancer
indicators,
miRNA-122,
down-regulated
miRNA
hepatocellular
carcinoma,
respectively.
Through
circuit,
to
at
femtomolar
level
well
visualized
inside
cells,
fixed
tissues,
mice
programmed.
Furthermore,
triggered
by
preloaded
miRNA-122
amplified
via
released
into
target
cells;
sudden
increase
simultaneous
decrease
miRNA-155
synergistically
served
drugs
regulation
with
enhanced
antitumor
efficacy
superior
biosafety.
It
envisioned
that
will
initiate
essential
step
toward
theranostics
personalized/precise
medicine.
Briefings in Bioinformatics,
Journal Year:
2024,
Volume and Issue:
25(2)
Published: Jan. 22, 2024
Connections
between
circular
RNAs
(circRNAs)
and
microRNAs
(miRNAs)
assume
a
pivotal
position
in
the
onset,
evolution,
diagnosis
treatment
of
diseases
tumors.
Selecting
most
potential
circRNA-related
miRNAs
taking
advantage
them
as
biological
markers
or
drug
targets
could
be
conducive
to
dealing
with
complex
human
through
preventive
strategies,
diagnostic
procedures
therapeutic
approaches.
Compared
traditional
experiments,
leveraging
computational
models
integrate
diverse
data
order
infer
associations
proves
more
efficient
cost-effective
approach.
This
paper
developed
model
Convolutional
Autoencoder
for
CircRNA-MiRNA
Associations
(CA-CMA)
prediction.
Initially,
this
merged
natural
language
characteristics
circRNA
miRNA
sequence
features
circRNA-miRNA
interactions.
Subsequently,
it
utilized
all
pairs
construct
molecular
association
network,
which
was
then
fine-tuned
by
labeled
samples
optimize
network
parameters.
Finally,
prediction
outcome
is
obtained
utilizing
deep
neural
networks
classifier.
innovatively
combines
likelihood
objective
that
preserves
neighborhood
optimization,
learn
continuous
feature
representation
words
preserve
spatial
information
two-dimensional
signals.
During
process
5-fold
cross-validation,
CA-CMA
exhibited
exceptional
performance
compared
numerous
prior
approaches,
evidenced
its
mean
area
under
receiver
operating
characteristic
curve
0.9138
minimal
SD
0.0024.
Furthermore,
recent
literature
has
confirmed
accuracy
25
out
top
30
identified
highest
scores
during
case
studies.
The
results
these
experiments
highlight
robustness
versatility
our
model.